PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

PhoenixBio Co., Ltd.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (5)

Compared with Healthcare companies in Japan.

P/E ratio

81.0

Investors pay 81.0 for every 1 of PhoenixBio Co., Ltd.'s yearly profit, higher than 95% of Healthcare companies in Japan.

P/B ratio

0.83

The share price is 0.83 times PhoenixBio Co., Ltd.'s book value per share, lower than 84% of Healthcare companies in Japan.

Market cap

¥1.2 B

The total market value of all of PhoenixBio Co., Ltd.'s shares at today's price (share price × number of shares), smaller than almost all Healthcare companies in Japan. PosiCap size class: Nano Cap.

Return on equity (ROE)

1.1%

PhoenixBio Co., Ltd. earned 1.1% on its shareholders' money over the last year, lower than 72% of Healthcare companies in Japan.

Dividend yield

None

PhoenixBio Co., Ltd. does not currently pay a dividend.

Questions

What is PhoenixBio Co., Ltd.'s P/E ratio?

Investors pay 81.0 for every 1 of PhoenixBio Co., Ltd.'s yearly profit, higher than 95% of Healthcare companies in Japan.

What is PhoenixBio Co., Ltd.'s return on equity?

PhoenixBio Co., Ltd. earned 1.1% on its shareholders' money over the last year, lower than 72% of Healthcare companies in Japan.

Does PhoenixBio Co., Ltd. pay a dividend?

No. PhoenixBio Co., Ltd. does not currently pay a dividend.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.